Srebp1 and its target genes including Fas, Acc, and Scd1 are up-regulated in NAFLD, and inhibiting Srebp1 activity impairs the induction of lipogenic Srebp1 target genes and TG accumulation (Bitter et al., 2015a, b). Here, ACACA is linked to metabolic dysfunction-associated steatotic liver disease.